These investigations reveal that IL-17 stimulates a diverse array of cytokines, chemokines, and inflammatory mediators, which collectively enhance tumor cell proliferation, migration, and invasion, inhibit apoptosis in tumor cells, undermine anti-tumor responses, promote angiogenesis, and facilitate tumor progression (7). The gene discussed is IL17A; the disease is neoplasm.